Waldron Private Wealth LLC Buys 332 Shares of MetLife, Inc. (NYSE:MET)

Waldron Private Wealth LLC lifted its holdings in MetLife, Inc. (NYSE:MET) by 4.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,150 shares of the financial services provider’s stock after buying an additional 332 shares during the quarter. Waldron Private Wealth LLC’s holdings in MetLife were worth $590,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. National Bank of Canada FI raised its holdings in shares of MetLife by 54.9% in the first quarter. National Bank of Canada FI now owns 371,062 shares of the financial services provider’s stock valued at $26,983,000 after buying an additional 131,538 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of MetLife in the first quarter valued at about $1,053,000. Entropy Technologies LP raised its holdings in shares of MetLife by 38.3% in the first quarter. Entropy Technologies LP now owns 30,473 shares of the financial services provider’s stock valued at $2,258,000 after buying an additional 8,440 shares during the last quarter. M&G Plc bought a new position in shares of MetLife in the second quarter valued at about $2,346,000. Finally, Canada Pension Plan Investment Board raised its holdings in shares of MetLife by 53.0% in the first quarter. Canada Pension Plan Investment Board now owns 618,650 shares of the financial services provider’s stock valued at $45,848,000 after buying an additional 214,367 shares during the last quarter. 89.81% of the stock is owned by institutional investors.

MetLife Trading Down 0.1 %

NYSE MET opened at $84.77 on Wednesday. The stock has a market capitalization of $60.28 billion, a price-to-earnings ratio of 29.13, a PEG ratio of 0.69 and a beta of 1.04. The stock’s 50 day moving average price is $79.11 and its two-hundred day moving average price is $74.29. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52 week low of $57.91 and a 52 week high of $86.94.

MetLife (NYSE:MET) last released its earnings results on Wednesday, July 31st. The financial services provider reported $2.28 EPS for the quarter, beating the consensus estimate of $2.13 by $0.15. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The firm had revenue of $17.82 billion for the quarter, compared to analysts’ expectations of $18.57 billion. During the same quarter in the previous year, the business posted $1.94 EPS. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. As a group, analysts anticipate that MetLife, Inc. will post 8.61 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.57%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio (DPR) is presently 74.91%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Wells Fargo & Company boosted their price objective on MetLife from $86.00 to $92.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. JPMorgan Chase & Co. boosted their price objective on MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a report on Tuesday, July 2nd. Morgan Stanley dropped their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a report on Monday, August 19th. Keefe, Bruyette & Woods dropped their price objective on MetLife from $86.00 to $85.00 and set an “outperform” rating for the company in a report on Monday, July 8th. Finally, Citigroup boosted their target price on MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $88.46.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.